Editorial: Beyond abstinence: harm reduction and its impact on addiction disorders
-
By
-
Miesha Marzell
-
June 26, 2026
-
0 min
Clinical Report: Moving Past Abstinence - The Role of Harm Reduction in Addressing Addiction Disorders
Overview
This editorial discusses harm reduction as a public health framework for addressing addiction disorders.
Background
Harm reduction has gained recognition as an approach in public health, particularly in the context of substance use disorders. Traditional models emphasizing abstinence may overlook the complexities of addiction.
Data Highlights
No specific numerical or trial data provided in the editorial.
Key Findings
- Harm reduction strategies encompass clinical treatment, psychosocial support, and public policy.
- Effective interventions focus on risk reduction and health improvements.
- Integrated treatment approaches yield strong outcomes for opioid use disorder.
- Community-informed service innovations can enhance access to harm reduction resources.
- Addressing social and structural factors is crucial for effective harm reduction.
Clinical Implications
Healthcare professionals should consider harm reduction in treating substance use disorders.
Conclusion
The editorial discusses harm reduction as an approach that addresses factors influencing substance use disorders.
Related Resources & Content
- Open Forum Infectious Diseases, 2023 -- Towards Comprehensive Approaches in Infectious Disease Management, Harm Reduction Strategies, and Primary Healthcare Integration
- DIGITAL HEALTH, 2023 -- Behavior change techniques in mobile health interventions promoting recovery from substances: A synthesis of reviews and meta-analyses
- JAMA Network Open, 2023 -- Projected Outcomes of Reducing Federal Funding for Syringe Service Programs via Executive Order
- Frontiers in Psychiatry — Augmenting neurocounseling in addiction recovery with intelligent systems: a roadmap for research and practice
- Substance Use Disorders - Statutes, Regulations, and Guidelines | SAMHSA
- Lifesaving Naloxone | Stop Overdose | CDC
- WHO updates guidelines on opioid dependence treatment and overdose prevention
- Federal Guidelines for Opioid Treatment Programs
- Linking People with Opioid Use Disorder to Medication Treatment | Overdose Prevention | CDC
- The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder - PMC
- Substance Use Harm Reduction in Medical Care - NCBI Bookshelf
- Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial - University of Miami
- Opioid Overdose After MOUD Initiation Following Hospitalization or ED Visit
- Emergency Department Peer Support Program and Patient Outcomes After Opioid Overdose
- Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration - ScienceDirect
- Supervised consumption sites and population-level overdose mortality: a systematic review of recent evidence, 2016–2024 - PMC
- Overdose Prevention Centers and Neighborhood Commercial Activity in New York City | Public Health | JAMA Network Open | JAMA Network
- Oral and injectable opioid agonist treatments for people who use street opioids: a systematic literature review and network meta-analysis - PMC
- Effectiveness and safety of therapies for patients with opioid use disorder: a systematic review and network meta-analysis - White Rose Research Online
- Beyond Fentanyl Test Strips: Investigating Other Urine Drug Test Strips for Drug Checking Applications | NIST
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
